Theravance Uses Organ-Selective R&D To Advance GI, Pulmonary Candidates

 
• By Joseph Haas
  
Back view image of young businessman standing against business sketch
Theravance expects 2021 to be a year of advancement for its pipeline
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip